Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

BACKGROUND: Primaquine is used to prevent Plasmodium vivax relapse; however, it is not implemented in many malaria-endemic countries, including Cambodia, for fear of precipitating primaquine-induced acute haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency (G6PDd). Reluc...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Kheng, Sim, Muth, Sinoun, Taylor, Walter R. J., Tops, Narann, Kosal, Khem, Sothea, Khon, Souy, Phum, Kim, Saorin, Char, Chuor Meng, Vanna, Chan, Ly, Po, Ringwald, Pascal, Khieu, Virak, Kerleguer, Alexandra, Tor, Pety, Baird, John K., Bjorge, Steven, Menard, Didier, Christophel, Eva
Formatua: Online Artikulua Texto
Hizkuntza:English
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549079/
https://www.ncbi.nlm.nih.gov/pubmed/26303162
http://dx.doi.org/10.1186/s12916-015-0441-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549079/
https://www.ncbi.nlm.nih.gov/pubmed/26303162
http://dx.doi.org/10.1186/s12916-015-0441-1

Antzeko izenburuak